Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Development of cardioplegic solution without potassium: experimental study in rat

Full text
Author(s):
Reichert, Karla [1] ; Pereira do Carmo, Helison Rafael [1] ; Lima, Fany [1] ; Torina, Anali Galluce [1] ; de Souza Vilarinho, Karlos Alexandre [1] ; Martins de Oliveira, Pedro Paulo [1] ; Silveira Filho, Lindemberg Mota [1] ; Barbosa de Oliveira Severino, Elaine Soraya [1] ; Petrucci, Orlando [1]
Total Authors: 9
Affiliation:
[1] Univ Estadual Campinas FCM Unicamp, Fac Ciencias Med, Campinas, SP - Brazil
Total Affiliations: 1
Document type: Journal article
Source: Revista Brasileira de Cirurgia Cardiovascular; v. 28, n. 4, p. 524-530, OCT-DEC 2013.
Web of Science Citations: 2
Abstract

INTRODUCTION: Myocardial preservation during open heart surgeries and harvesting for transplant are of great importance. The heart at the end of procedure has to resume its functions as soon as possible. All cardioplegic solutions are based on potassium for induction of cardioplegic arrest. OBJECTIVE: To assess a cardioplegic solution with no potassium addition to the formula with two other commercially available cardioplegic solutions. The comparative assessment was based on cytotoxicity, adenosine triphosphate myocardial preservation, and caspase 3 activity. The tested solution (LIRM) uses low doses of sodium channel blocker (lidocaine), potassium channel opener (cromakalin), and actin/myosin cross bridge inhibitor (2,3-butanedione monoxime). METHODS: Wistar rats underwent thoracotomy under mechanical ventilation and three different solutions were used for "in situ" perfusion for cardioplegic arrest induction: Custodiol (HTK), Braile (G/A), and LIRM solutions. After cardiac arrest, the hearts were excised and kept in cold storage for 4 hours. After this period, the hearts were assessed with optical light microscopy, myocardial ATP content and caspase 3 activity. All three solutions were evaluated for direct cytotoxicity with L929 and WEHI-164 cells. RESULTS: The ATP content was higher in the Custodiol group compared to two other solutions (P<0.05). The caspase activity was lower in the HTK group compared to LIRM and G/A solutions (P<0.01). The LIRM solution showed lower caspase activity compared to Braile solution (P<0.01). All solutions showed no cytotoxicity effect after 24 hours of cells exposure to cardioplegic solutions. CONCLUSION: Cardioplegia solutions without potassium are promised and aminoacid addition might be an interesting strategy. More evaluation is necessary for an optimal cardioplegic solution development. (AU)

FAPESP's process: 12/09130-1 - Development of cardioplegic solution for heart transplant and conventional open-heart surgeries.
Grantee:Orlando Petrucci Jr
Support Opportunities: Regular Research Grants